Huperzine A for mild cognitive impairment

BACKGROUND: Mild cognitive impairment (MCI) has been proposed as a condition of intermediate symptomatology between the cognitive changes of ageing and fully developed symptoms of dementia. Treatment in the stages of MCI may delay the deterioration of cognitive impairment and delay the progression t...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane Database Syst Rev
Main Authors: Yue, Jirong, Dong, Bi Rong, Lin, Xiufang, Yang, Ming, Wu, Hong Mei, Wu, Taixiang
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2012
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464949/
https://ncbi.nlm.nih.gov/pubmed/23235666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008827.pub2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items